Liver Cirrhosis Completed Phase 3 Trials for Rifaximin (DB01220)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03695705Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated CirrhosisPrevention
NCT02016196Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPSTreatment